{ "ok": true, "cik": "1192448", "ticker": "GKOS", "name": "GLAUKOS Corp", "filings": [ { "form": "8-K", "filed": "2026-08-03", "items": [ "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1192448/000119244826000002/0001192448-26-000002-index.htm" }, { "form": "10-Q", "filed": "2026-07-29", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1192448/000119312526324201/0001193125-26-324201-index.htm" }, { "form": "8-K", "filed": "2026-07-29", "items": [ "2.02 Results of Operations and Financial Condition", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1192448/000119312526323729/0001193125-26-323729-index.htm" }, { "form": "8-K", "filed": "2026-06-03", "items": [ "5.07 Submission of Matters to a Vote of Security Holders" ], "url": "https://www.sec.gov/Archives/edgar/data/1192448/000119312526255758/0001193125-26-255758-index.htm" }, { "form": "8-K", "filed": "2026-05-04", "items": [ "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1192448/000119312526202466/0001193125-26-202466-index.htm" }, { "form": "10-Q", "filed": "2026-04-30", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1192448/000119312526193004/0001193125-26-193004-index.htm" } ], "events12m": 10, "healthWatch": { "window": "last 12 months", "since": "2025-09-26", "signals": [], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001192448.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1192448" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up GLAUKOS Corp ($GKOS). Last filing: 8-K (7.01 Regulation FD Disclosure), 2026-08-03. 10 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 507442000, "revenueGrowth1y": 0.3232519994471694, "revenueGrowthPerYear": 0.14618760521031304, "yearsOfData": 5, "operatingMargin": -0.39334544637613755, "operatingMarginPrior": -0.31909273210406774, "netMargin": -0.3698767543876936, "operatingCashFlow": -14789000, "capitalSpending": 7666000, "freeCashFlow": -22455000, "researchAndDevelopment": 150614000, "researchShareOfRevenue": 0.2968102758541863, "cash": 90813000, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 294011000 }, { "fiscalYearEnd": "2022-12-31", "revenue": 282862000 }, { "fiscalYearEnd": "2023-12-31", "revenue": 314711000 }, { "fiscalYearEnd": "2024-12-31", "revenue": 383481000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 507442000 } ], "totalEquity": 656155000, "totalAssets": 893487000, "equityRatio": 0.7343755421175686, "returnOnEquity": -0.2860467420045569, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": -3.28, "sharesOutstanding": 57190000, "bookValuePerShare": 11.473247071166288, "revenuePerShare": 8.872914845252666, "range80": { "low": 518525187.05265504, "high": 769911692.3911855, "baseline": 644027467.0898014, "n": 4309, "band": "b01", "bandLabel": "$100M–1B", "method": "v4.1", "credibility": 0.5, "growthYears": 4, "ownVolatility": 0.13653438303485738, "classVolatility": 0.1022985825903761, "volatility": 0.12063713721468432 }, "ifPaceHeld": { "low": 518525187.05265504, "high": 769911692.3911855 } }, "edgarette": "🔖 Exposure: revenue $507.4M (FY2025). Experience: revenue up 32.3% on the year, up 14.6% a year over 4 years; operating margin -39.3%, down from -31.9%. Soundness: equity 73.4% of assets, return on equity -28.6%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $518.5M and $769.9M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; on a year the method never saw, 83.4% landed inside). In a shock year the stress range is $469.2M to $854.3M. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -39.3% against a 1.2% median; growth 32.3% against 11.6%.", "peers": { "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "3841", "growth": [ 0.1161, 60 ], "opMargin": [ 0.0124, 60 ], "equityRatio": [ 0.5291, 59 ], "returnOnEquity": [ -0.0233, 55 ], "payoutRatio": [ 0.3812, 8 ] }, "summary": "Glaukos (GKOS) grew revenue 32.3% in FY2025 to $507 million, operating margin -39.3% against a 1.2% median for surgical & medical instruments & apparatus, equity 73.4% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
GLAUKOS Corp against its own record and its peers
Operating marginPeer median 1.2%-39.3%Revenue, on the yearPeer median 11.6%32.3%Equity of assetsPeer median 52.9%73.4%Return on equityPeer median -2.3%-28.6%Gold tick: the median of 55–59 peers with $50M+ revenue in surgical & medical instruments & apparatus
", "chartHorizon": null, "backtest": { "tests": 9, "hits": 7, "rate": 0.7777777777777778, "method": "v4", "byYear": { "2017": [ 1, 1 ], "2018": [ 1, 1 ], "2019": [ 1, 1 ], "2020": [ 1, 1 ], "2021": [ 0, 1 ], "2022": [ 0, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-26T15:57:20.522Z", "hash": "3b06f3b51e7c4a85", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Glaukos (GKOS) grew revenue 32.3% in FY2025 to $507 million, operating margin -39.3% against a 1.2% median for surgical & medical instruments & apparatus, equity 73.4% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 507442000, "totalDebt": null, "cash": 90813000 }, "experience": { "revenueGrowth1y": 0.3232519994471694, "revenueGrowthPerYear": 0.14618760521031304, "operatingMargin": -0.39334544637613755, "operatingMarginPrior": -0.31909273210406774, "netMargin": -0.3698767543876936, "freeCashFlow": -22455000 }, "soundness": { "equityRatio": 0.7343755421175686, "returnOnEquity": -0.2860467420045569, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "3841", "growth": [ 0.1161, 60 ], "opMargin": [ 0.0124, 60 ], "equityRatio": [ 0.5291, 59 ], "returnOnEquity": [ -0.0233, 55 ], "payoutRatio": [ 0.3812, 8 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-09-26", "signals": [], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 518525187.05265504, "high": 769911692.3911855, "baseline": 644027467.0898014, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 4309, "sizeBand": "$100M–1B", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341 }, "credibility": { "weightOnOwnRecord": 0.5, "growthYears": 4, "ownVolatility": 0.13653438303485738, "classVolatility": 0.1022985825903761, "pricedVolatility": 0.12063713721468432, "k": 3 }, "stress": { "low": 469180320.0083714, "high": 854309552.8874419, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 9, "hits": 7, "rate": 0.7777777777777778, "method": "v4", "byYear": { "2017": [ 1, 1 ], "2018": [ 1, 1 ], "2019": [ 1, 1 ], "2020": [ 1, 1 ], "2021": [ 0, 1 ], "2022": [ 0, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-26T15:57:20.522Z", "hash": "3b06f3b51e7c4a85", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001192448.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1192448" }, "speedCash": { "fiscalYear": 2025, "cashConversion": -0.0291, "growth3y": 0.2151, "volatility": 0.1365, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.7344, "quadrant": { "code": "fj", "label": "Fast and jumpy", "plain": "growing faster than its size class, with revenue that swings more" }, "compass": { "code": "notyet", "inside": "Turns -2.9% of revenue into operating cash; revenue growing 21.5% a year over three years; no common dividend.", "outside": "Among $100M-1B companies: 19th percentile for cash, 79th for growth.", "emoji": "⚡", "label": "Fast, cash not yet", "plain": "growing fast, but little cash arriving so far" }, "band": "$100M-1B", "cashPctInClass": 19, "growthPctInClass": 79, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "cash", "text": "operating cash flow was negative" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 1, "name": "Sound ship", "plain": "one warning sign" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -14789000, "investing": -77613000, "financing": 11886000, "capitalSpending": 7666000, "free": -22455000, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": 24708000, "free": -23077000 }, { "fiscalYearEnd": "2022-12-31", "operating": -33083000, "free": -63348000 }, { "fiscalYearEnd": "2023-12-31", "operating": -57758000, "free": -78006000 }, { "fiscalYearEnd": "2024-12-31", "operating": -61318000, "free": -67618000 }, { "fiscalYearEnd": "2025-12-31", "operating": -14789000, "free": -22455000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 90813000, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 893487000, "ladder": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": { "fiscalYear": 2025, "cashConversion": -0.0291, "growth3y": 0.2151, "volatility": 0.1365, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.7344, "quadrant": { "code": "fj", "label": "Fast and jumpy", "plain": "growing faster than its size class, with revenue that swings more" }, "compass": { "code": "notyet", "inside": "Turns -2.9% of revenue into operating cash; revenue growing 21.5% a year over three years; no common dividend.", "outside": "Among $100M-1B companies: 19th percentile for cash, 79th for growth.", "emoji": "⚡", "label": "Fast, cash not yet", "plain": "growing fast, but little cash arriving so far" }, "band": "$100M-1B", "cashPctInClass": 19, "growthPctInClass": 79, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "cash", "text": "operating cash flow was negative" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 1, "name": "Sound ship", "plain": "one warning sign" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -14789000, "investing": -77613000, "financing": 11886000, "capitalSpending": 7666000, "free": -22455000, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": 24708000, "free": -23077000 }, { "fiscalYearEnd": "2022-12-31", "operating": -33083000, "free": -63348000 }, { "fiscalYearEnd": "2023-12-31", "operating": -57758000, "free": -78006000 }, { "fiscalYearEnd": "2024-12-31", "operating": -61318000, "free": -67618000 }, { "fiscalYearEnd": "2025-12-31", "operating": -14789000, "free": -22455000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 90813000, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 893487000, "ladder": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }